| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
|
Designated Validation States: |
|
KH MA MD TN |
| (30) |
Priority: |
25.03.2019 US 201962823455 P
15.05.2019 US 201962848272 P
04.10.2019 WO PCT/US2019/054833
22.01.2020 US 202062964397 P
12.02.2020 US 202062975611 P
|
| (71) |
Applicants: |
|
- Xenotherapeutics, Inc.
Boston, Massachusetts 02115 (US)
- Xenotherapeutics Corporation
Enfield, New Hampshire 03748 (US)
|
|
| (72) |
Inventors: |
|
- HOLZER, Paul, W.
Grantham, NH 03753 (US)
- ADKINS, Jon
Londonderry, NH 03053 (US)
- MON ROY, Rodney, L.
North Fort Myers, FL 33903 (US)
- CHANG, Elizabeth, J.
Pittsford, NY 14534 (US)
|
| (74) |
Representative: Grünecker Patent- und Rechtsanwälte
PartG mbB |
|
Leopoldstraße 4
80802 München
80802 München (DE) |
|
